LM Industries Brings Manufacturing Into the Future as World's First Digital OEM
The creators of autonomous shuttle Olli form LM Industries, a company designing and building future-looking products with partners like Allianz, Airbus and the United States Marine Corps
LM Industries creates transportation, accessibility and mobility products with customers such as Allianz Group, Airbus and the United States Marine Corps, by combining co-creation, technology, and microfactories into one modern manufacturing process that builds high-quality, low-volume products at unprecedented speeds. Its efficiency allows products to be upgradeable like software - iterated regularly and fluidly to match rapidly changing consumer preferences. Bringing Launch Forth's design and Local Motor's microfactories into one parent company provides clients with a better alternative to mass manufacturing that gets the right products into the right people's hands at the right time. With shared resources and capabilities, LM Industries will explore more ambitious and ground-breaking projects to solve the most pressing issues of our time.
"Mass manufacturing is a relic of a past era. We're in the middle of a mobility revolt where current modes of transportation are not sustainable and do not match up with rapidly changing consumer preferences," said LM Industries CEO and co-founder John B. Rogers, Jr. "We can't keep producing products the same way we've been accustomed to. The world is moving too fast for traditional manufacturing to keep up. LM Industries is on a mission to transform mass manufacturing to micro-manufacturing in order to match the new pace of technology and quickly changing consumer needs."
Allianz is partnering with Local Motors to deploy Olli in multiple cities in order to help accelerate the understanding of insurance in our shared, autonomous world. The global insurer is also designing new mobility solutions and imagining the future of mobility insurance with Launch Forth. Now Jean-Marc Pailhol, Head of Global Market Management & Distribution at Allianz SE, joins the LM Industries board to help guide future product development and encourage strategic global partnerships.
"Because they will be pushed by pollution and traffic constraints, the large cities will be the first to accept and implement the disruptive mobility products such as autonomous or flying vehicles for public transportation. LM Industries checks all the boxes with its product features: 100% electric, 100% autonomous, 100% connected and 90% 3D printed with the ability to produce in micro factories near bigger cities," said Pailhol. "In the future, a large part of the mobility market will be taken by small factories making solutions near the cities in which they are needed. LM Industries has a real competitive advantage in that they are a step ahead of the other AV manufacturers and have a real value proposition with their microfactories. When I met Jay Rogers nearly two years ago, I quickly recognized the relevance of his value proposition from co-creation to micro-manufacturing to mobility solutions like Olli."
The latest project from Allianz and LM Industries is an accessibility device that can be customized to match any activity level or style choices. For the past 150 years, the design of the wheelchair has remained fundamentally the same, with the same benefits and many of the same problems. With limited upgradability and the stigma of a medical device, it is time for a major shift in mass mobility that is inclusively designed with accessibility in mind, but that is also functional and fun for all people.
Other in-progress projects include a modular logistics vehicle and an unmanned cargo system with the United States Marine Corps. The success of this effort shows the elasticity and nimbleness of LM Industries to provide on-target solutions in both the commercial and military sectors. If this project continues to achieve results ahead of schedule, it stands to augment the US military with a much needed responsive capability for vehicle systems development.
"LM Industries has proven to be an agile, adaptive, and innovative partner in maturing our hybrid logistics vision," said Lieutenant General Michael G. Dana, Deputy Commandant for Installation and Logistics. "Through the Launch Forth initiative, we are developing critically needed logistical capabilities for 21st century expeditionary operations. By leveraging the power of co-creation, we will rapidly develop time sensitive, demand-driven capabilities for our Marines."
"As we have proven with Olli and other products, we can change designs based on consumer preferences in a day and custom-develop a fleet of large machines in a matter of weeks," said Rogers. "Our vision goes far beyond ground mobility; our manufacturing process can be applied to virtually any hardware product, from aviation to infrastructure, housing and other large industrial products. If Amazon created a new eco-system to monetize the long-tail of ordering things, LM Industries has created an ecosystem to monetize the long-tail of making things. Ecosystem shifts like this come once in a century."
About LM Industries
LM Industries exists to shape the future for the better. We make technology forward products using the four pillars of our innovation ecosystem: co-creation, microfactories, direct digital manufacturing, lab partnerships. We begin every product with community-powered, human-centered design and by reinventing manufacturing with microfactories, we create big things on a smaller scale for the local communities that actually need them. Our process breaks down the barriers to sustainable product development - reducing waste, consuming less energy, and ensuring we use only the materials we need. We have the unrivaled capacity to make the improbable come to life. Based in San Francisco, LM Industries is the parent company of Local Motors and Launch Forth.
LaunchSquad for LM Industries
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LM Industries via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 201817.7.2018 22:30 | Pressmeddelande
LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the meeting, all resolutions for which management recommended a vote in favor, were adopted, including: - Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2017 and quietus of directors; - Allocation of the financial year's results; - Approval of regulatory agreements and commitments referred to in Article L.225-38 of the French Commercial Code; - Approval of the regulations of the share subscription and/or purchase options plan adopted by the Board of Directors on June 27, 2017; - Authorization for the Board of Directors to grant share subscription and/or share purchase options and/or to issue detachable share subscription warrants to corporate officers and employees of the Company or companies in the ERYTECH Pharma
Williams Scotsman Receives Competition Bureau Clearance for ModSpace Acquisition17.7.2018 22:15 | Pressmeddelande
BALTIMORE, July 17, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (NASDAQ:WSC) ("Williams Scotsman"), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that, on July 16, 2018, the Canadian Competition Bureau issued a No Action Letter relating to Williams Scotsman's proposed acquisition of Modular Space Corporation ("ModSpace"). WillScot has now obtained the regulatory approvals required to complete the acquisition and continues to progress towards closing in the third quarter of 2018. About Williams Scotsman Headquartered in Baltimore, Maryland, WillScot Corporation is the public holding company for the Williams Scotsman family of companies in the United States, Canada and Mexico. WillScot Corporation trades on the NASDAQ stock exchange under the ticker symbol "WSC." Williams Scotsman is a specialty rental services market leader providing innovative modular space and portable storage solutio
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors17.7.2018 22:05 | Pressmeddelande
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the election of Jeryl Hilleman to the Board of Directors of the Company. "Jeri brings a broad life sciences background to Minerva that includes high growth commercial biopharma, med-tech and data science companies," said William F. Doyle, Lead Independent Director of Minerva. "Her track record of delivering strategic and financial growth through execution, strategic partnering and multiple acquisitions will serve Minerva well as the Company completes five ongoing late-stage clinical trials with roluperidone, seltorexant and MIN-117." Ms. Hilleman is presently Chief Financial Officer of Intersect ENT (NASDAQ:XENT), a medical device company with commercial products for the treatment of chronic sinusitis. Previously, she served as CFO of several public
Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide17.7.2018 21:00 | Pressmeddelande
OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a grant of $2M US dollars by the National Center for Research and Development . The grant will fund a project to advance development of the company's innovative microbicide candidate (OB-002H). Designed to prevent the transmission of HIV, OB-002H has the potential to address an urgent and growing need for an HIV prevention product that is affordable, appealing to use, and easily integrates into the lifestyles of people at risk for HIV infection regardless of age, sex or gender. The project is co-financed by the National Center for Research and Development under the InnoNeuroPharm program - Measure 1.2: Sectoral R & D programs of the Intelligent Development Operational Program 2014-2020. Orion Biotechnology will use the grant to complete IND enabling studies, advance OB-002H to
Greater Anglia Selects PowerPlan to Optimise Its Asset Investments17.7.2018 15:29 | Pressmeddelande
ATLANTA, July 17, 2018 (GLOBE NEWSWIRE) -- Greater Anglia, a UK-based train operating company, has selected PowerPlan's Asset Investment Optimization software suite to maximise its asset investments over a 40-year time period. Greater Anglia's long-term investment strategy includes a 40-year asset plan to meet its regulatory requirements. For what was historically built with manual processes and not easily tracked, the Asset Investment Optimization solution from PowerPlan will provide a comprehensive, auditable approach to help the company analyze different investment scenarios for impacts to risk, cost, timing and level of service and provide a defendable asset plan for the next four decades. "The condition of our assets drives our business," said Richard Turner, Head of Asset Management for Greater Anglia. "With PowerPlan, we can apply a fact-based methodology to prioritise investments, maximise their return and produce plans that communicate our asset strategy to internal and extern
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 201817.7.2018 14:30 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 9268558, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com. The replay will be available on the Company's website for approximately
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum